Arcutis Biotherapeutics (ARQT)
$11.71 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
7 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Arcutis Biotherapeutics, AI stock picks, stock alerts and much more.
ARQT AI Stock Analysis
AI stock analysis for ARQT is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Arcutis Biotherapeutics (ARQT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
ARQT Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Arcutis Biotherapeutics (ARQT), currently trading at $11.71, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ARQT
-
Arcutis Biotherapeutics, Inc.
-
Symbol
ARQT
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
1.4B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.34 1.9% |
6 |
 |
Inovio Pharmaceuticals INO |
$4.19 4.5% |
2 |
 |
Moderna MRNA |
$43.39 3.2% |
4 |
 |
Anavex Life Sciences AVXL |
$9.03 0.1% |
4 |
 |
BridgeBio Pharma BBIO |
$27.49 4% |
5 |
News
ARQT Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Facebook Engagement
Sign up to access
LinkedIn Followers
Sign up to access
LinkedIn Employees
Sign up to access
Job Postings
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
ARQT Financials
ARQT Key Metrics
-
Total Revenue
$44.8M
-
Net Income
-$41.5M
-
Earnings per Share
-$0.0003
-
Free cash flow
-$34.8M
-
EBITDA
-$39.1M
-
EBITDA Ratio
-0.872886
-
Total Assets
$437.4M
ARQT 2-year Revenue & Income
ARQT 2-year Free Cash Flow
ARQT Technicals
ARQT SMA
ARQT RSI
FAQ
What's the current price of Arcutis Biotherapeutics (ARQT) Stock?
The price of an Arcutis Biotherapeutics (ARQT) share is $11.71.
What's the market cap of Arcutis Biotherapeutics?
The current market cap of Arcutis Biotherapeutics is 1.4B.
Should I buy or sell ARQT?
Arcutis Biotherapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Arcutis Biotherapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Arcutis Biotherapeutics a good investment?
The current analysis of Arcutis Biotherapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Arcutis Biotherapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Arcutis Biotherapeutics (ARQT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Arcutis Biotherapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Arcutis Biotherapeutics (ARQT) that investors often compare it to?
Arcutis Biotherapeutics (ARQT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Arcutis Biotherapeutics' stock price in 2025?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Arcutis Biotherapeutics' stock price to be around $11.61 in 2025. Starting from the current price of $11.71, this represents a 0.8% change in price, indicating a neutral outlook for the stock.
How to buy Arcutis Biotherapeutics (ARQT) Stock?
Arcutis Biotherapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Arcutis Biotherapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.